Tamoxifen in cancer therapy: minireview

Neoplasma. 2000;47(1):3-7.

Abstract

Tamoxifen belongs among relatively new drugs. As it has already been shown, it undoubtedly brings a benefit to oncology patients. However, there are still questions regarding its broader use in therapy or cancer prevention. This review puts together some data available at present time with the aim of elucidating the most important aspects of its use in medical oncology.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / chemistry
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / prevention & control*
  • Endometrial Neoplasms / chemically induced
  • Estrogen Antagonists / adverse effects
  • Estrogen Antagonists / chemistry
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Humans
  • Male
  • Medical Oncology
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Tamoxifen / adverse effects
  • Tamoxifen / chemistry
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Antagonists
  • Tamoxifen